BR0110969A - Inibição de pepsina por alginatos - Google Patents

Inibição de pepsina por alginatos

Info

Publication number
BR0110969A
BR0110969A BR0110969-3A BR0110969A BR0110969A BR 0110969 A BR0110969 A BR 0110969A BR 0110969 A BR0110969 A BR 0110969A BR 0110969 A BR0110969 A BR 0110969A
Authority
BR
Brazil
Prior art keywords
alginates
pepsin
inhibition
exhibit
gastric juice
Prior art date
Application number
BR0110969-3A
Other languages
English (en)
Inventor
Peter William Dettmar
Frank Chadwick Hampson
Andrew Michael Sunderland
Jeffrey Peter Pearson
Original Assignee
Reckitt Benckiser Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt Benckiser Healthcare Ltd filed Critical Reckitt Benckiser Healthcare Ltd
Publication of BR0110969A publication Critical patent/BR0110969A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"INIBIçãO DE PEPSINA POR ALGINATOS". Certos alginatos apresentam uma capacidade superior de inibir a atividade proteolítica de pepsina e/ou suco gástrico. Em particular, alginatos tendo um peso molecular entre 40.000 e 350.000 apresentam uma inibição superior da atividade proteolítica de pepsina e suco gástrico acima de 50%, quando medida usando um ensaio de N-terminal.
BR0110969-3A 2000-05-19 2001-05-17 Inibição de pepsina por alginatos BR0110969A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0012094.9A GB0012094D0 (en) 2000-05-19 2000-05-19 Pharmaceutical compositions
PCT/GB2001/002143 WO2001087282A2 (en) 2000-05-19 2001-05-17 Pepsin inhibition by alginates

Publications (1)

Publication Number Publication Date
BR0110969A true BR0110969A (pt) 2003-04-15

Family

ID=9891899

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0110969-3A BR0110969A (pt) 2000-05-19 2001-05-17 Inibição de pepsina por alginatos

Country Status (14)

Country Link
US (1) US20030176394A1 (pt)
EP (2) EP1676585A1 (pt)
CN (1) CN1237977C (pt)
AT (1) ATE333884T1 (pt)
AU (2) AU2001258538B2 (pt)
BR (1) BR0110969A (pt)
CA (1) CA2410013A1 (pt)
DE (1) DE60121771T2 (pt)
ES (1) ES2269393T3 (pt)
GB (2) GB0012094D0 (pt)
HK (1) HK1057470A1 (pt)
PT (1) PT1301190E (pt)
WO (1) WO2001087282A2 (pt)
ZA (1) ZA200209806B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008082948A2 (en) * 2006-12-29 2008-07-10 Bausch & Lomb Incorporated Ophthalmic alginate composition related methods of manufacture and methods of use
WO2010108494A1 (en) * 2009-03-25 2010-09-30 S-Biotek Holding Aps Dayspepsia treatment with alginate
GB0920633D0 (en) * 2009-11-25 2010-01-13 Rdbiomed Ltd Inhibition of pancreatic lipase
BR112012026860A2 (pt) 2010-04-23 2018-06-05 S Biotek Holding Aps composição farmacêutica sólida para neutralizar ácido estomacal
DE102012022778A1 (de) * 2012-11-22 2014-06-05 Siegfried Wegener Arzneimittel gegen krebs, herzinfarkt und tuberkulose sowie gegen sämtliche krankheiten
CN104922682A (zh) * 2014-03-20 2015-09-23 中国科学院大连化学物理研究所 一种胰蛋白酶抑制剂及其应用
KR20150122293A (ko) * 2014-04-22 2015-11-02 에스케이이노베이션 주식회사 이차전지용 음극바인더, 이차전지용 전극 및 이를 포함하는 이차전지
IT201800002625A1 (it) * 2018-02-13 2019-08-13 Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L Composizione in forma solida per uso nel trattamento dei sintomi extra-esofagei del reflusso gastrico
CA3224252A1 (en) * 2021-07-05 2023-01-12 Reflux Gourmet Llc Alginate, polylysine, and seed preservative nutritional product and digestive aid

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1524740A (en) * 1976-11-09 1978-09-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions for use in the suppression of gastric reflux
GB1566609A (en) * 1977-03-10 1980-05-08 Reckitt & Colmann Prod Ltd Pharmaceutical compositions containing cholestyramine and alginic acid
WO1982000762A1 (en) * 1980-09-03 1982-03-18 Daigo H Agent for alimentary canal
IT1263755B (it) * 1991-09-16 1996-08-29 Fidia Spa Uso di esteri della colina con polisaccaridi acidi come agenti antiulcera e gastroprotettivi
JPH06256189A (ja) * 1993-03-04 1994-09-13 Snow Brand Milk Prod Co Ltd アセタミド−アルギン酸配合体を有効成分とする抗潰瘍薬
GB9322314D0 (en) * 1993-10-29 1993-12-15 Scherer Ltd R P Foam generating capsules
GB2298365B (en) * 1995-03-03 1997-05-07 Reckitt & Colmann Prod Ltd A liquid pharmaceutical composition alginate and potassium bicarbonate
GB9708772D0 (en) * 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions
GB9708773D0 (en) * 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions
GB9812426D0 (en) * 1998-06-10 1998-08-05 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
GB0005743D0 (en) * 2000-03-10 2000-05-03 Reckitt & Colmann Prod Ltd Pharmaceutical compositions including alginates

Also Published As

Publication number Publication date
EP1301190A2 (en) 2003-04-16
AU2001258538B2 (en) 2005-04-21
AU5853801A (en) 2001-11-26
ZA200209806B (en) 2003-12-03
GB0012094D0 (en) 2000-07-12
HK1057470A1 (en) 2004-04-08
ES2269393T3 (es) 2007-04-01
DE60121771D1 (de) 2006-09-07
WO2001087282A3 (en) 2002-06-06
PT1301190E (pt) 2006-12-29
CN1237977C (zh) 2006-01-25
EP1301190B1 (en) 2006-07-26
CN1430517A (zh) 2003-07-16
GB0112168D0 (en) 2001-07-11
DE60121771T2 (de) 2007-08-09
WO2001087282A2 (en) 2001-11-22
US20030176394A1 (en) 2003-09-18
GB2365771B (en) 2003-09-03
ATE333884T1 (de) 2006-08-15
GB2365771A (en) 2002-02-27
CA2410013A1 (en) 2001-11-22
EP1676585A1 (en) 2006-07-05

Similar Documents

Publication Publication Date Title
IL209189A0 (en) Copolymer 1 related polypeptides and their use as molecular weight markers
BR0216099B1 (pt) "conjunto de desgaste".
DK0960127T3 (da) Isoleret dimert fibroblastaktiverende protein-alfa og anvendelser deraf
BR0009480A (pt) Soluções de poliuretano com unidades de estrutura de alcoxissilano
FR2679914B1 (fr) Composition de caoutchouc de la serie des dienes connjuguees.
DE60120712D1 (en) Kallikrein gen
BR0110969A (pt) Inibição de pepsina por alginatos
IT1304499B1 (it) Procedimento per ridurre il peso molecolare di copolimeri eterpolimeri dell'etilene.
IT1304008B1 (it) Dispositivo per l'eliminazione di ratti e simili.
FR2842087B3 (fr) Dispositif d'extension de chaise ou de lit.
NO20032597L (no) Anvendelse av SARP-1 for behandlingen og/eller forebyggingen av skleroderma
ATE342957T1 (de) Waschmittelformkörper mit viskoelastischer phase
BR0114065A (pt) Triazolo-epotilonas
BR9909529A (pt) Maleato de paroxetina
BR9915093B1 (pt) composição polimérica modificada com borracha melhorada.
DE69715196D1 (de) Modifizierte form des hydrochlorids der r(-)-n-(4,4-di(-3-methylthien-2-yl)but-3-enyl)-nipecotinsäure
NO20021429D0 (no) 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner
FR2700886B1 (fr) Membrane élastique d'étanchéité pour bouton poussoir.
DE69012616D1 (de) Stabilisatoren mit N-hydroxy-substituierter, gehinderter Aminogruppe und ihre Herstellung durch Michael-Addition.
ITRM20000026V0 (it) Struttura integrata per attivita' fisiche e/o estetiche per il corpo.
ITVC980018A0 (it) Biscotti "le risaiole".
AU8566101A (en) A novel polypeptide, a human peroxidase 13 and the polynucleotide encoding the polypeptide
RU2002113445A (ru) Дезинфицирующее средство "дезимин"
ATE82855T1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosidphosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
AU4824601A (en) A novel polypeptide, a human plasminogen activator inhibitor 10 and the polynucleotide encoding the polypeptide

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]

Free format text: DE ACORDO COM ART. 34 " II " DA LPI ( LEI 9279, DE 14/05/96 ) , O EXAME FICA SUSPENSO PARA QUE O REQUERENTE APRESENTE DOCUMENTOS NECESSARIOS A REGULARIZACAO DO PROCESSO E EXAME DO PEDIDO.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]